Previous Page  4 / 13 Next Page
Information
Show Menu
Previous Page 4 / 13 Next Page
Page Background

Page 56

Notes:

conferenceseries

.com

Volume 7, Issue 9 (Suppl)

Gynecol Obstet (Sunnyvale), an open access journal

ISSN: 2161-0932

Gynecologic Cancers 2017

August 29-30, 2017

2

nd

International Congress on

August 29-30, 2017 | London, UK

Contemporary Issues in

Women Cancers & Gynecologic Oncology

Improving cervical cancer screening in Ghana using biomarkers

Ama Afrah

University of Ghana, Ghana

S

creening and management of abnormal cytology has resulted in a marked reduction in invasive cervical cancer using

Pap smear. However many women screened are not found to have significant precursor lesions. This is due to the poor

specificity of high-risk human papillomavirus triage. More specific cervical cancer biomarkers may be more effective triage

tools. Molecular markers have been extensively investigated with a view to providing early and accurate information on and

prediction of response to treatment of early cervical cancer. Proliferation is a key feature of the progression of tumors and is

now widely estimated by the immunocytochemical assessment of the nuclear antigen Ki-67. The proliferative rate determined

with Ki-67 antibody may provide information regarding cell kinetics of cervical carcinoma and their precursor lesions with

high rate of cell proliferation, potentially useful in identifying patients in order to improve the therapeutic approach, by a rapid,

practical and easily performed immunocytochemicalmethod. p16 on the other hand is alsowidely used as immunocytochemical

marker in gynecologic pathology and for that matter Pap smears. Strong and diffuse cytoplasmic and nuclear expression of p16

in squamous cell carcinoma of the female genital tract is strongly associated with high-risk human papilloma virus infection

and neoplasms of cervical origin. The majority of squamous cell carcinomas of uterine cervix express p16. This study will

evaluate whether a dual stain for p16 and Ki-67 may improve the triage of abnormal Pap smears.

Biography

Ama Afrah has MPhil in Pathology and BSc in Medical Laboratory Sciences. She is currently pursuing PhD in Applied Parasitology. She is a Cytologist at Korle-bu

Teaching Hospital. She has 3 publications to her credit.

aafrah@st.ug.edu.gh

Ama Afrah, Gynecol Obstet (Sunnyvale) 2017, 7:9 (Suppl)

DOI: 10.4172/2161-0932-C1-019